P.J. Gomes

1.1k total citations
19 papers, 713 citations indexed

About

P.J. Gomes is a scholar working on Public Health, Environmental and Occupational Health, Immunology and Allergy and Dermatology. According to data from OpenAlex, P.J. Gomes has authored 19 papers receiving a total of 713 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Public Health, Environmental and Occupational Health, 9 papers in Immunology and Allergy and 5 papers in Dermatology. Recurrent topics in P.J. Gomes's work include Ocular Surface and Contact Lens (11 papers), Allergic Rhinitis and Sensitization (9 papers) and Contact Dermatitis and Allergies (5 papers). P.J. Gomes is often cited by papers focused on Ocular Surface and Contact Lens (11 papers), Allergic Rhinitis and Sensitization (9 papers) and Contact Dermatitis and Allergies (5 papers). P.J. Gomes collaborates with scholars based in United States, United Kingdom and Portugal. P.J. Gomes's co-authors include Hui Li, Mark B. Abelson, Lisa M. Smith, Donna Welch, George W Ousler, William W. Storms, William E. Berger, Stanley P. Galant, Graça Miranda Silva and Jon I. Williams and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Allergy and Clinical Immunology and Investigative Ophthalmology & Visual Science.

In The Last Decade

P.J. Gomes

18 papers receiving 694 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
P.J. Gomes United States 6 375 354 181 128 85 19 713
Takayuki Motoki Japan 15 92 0.2× 284 0.8× 45 0.2× 55 0.4× 222 2.6× 35 689
Adewale Adeyinka Sweden 14 459 1.2× 642 1.8× 22 0.1× 26 0.2× 265 3.1× 26 1.0k
Kristen L. Lozada United States 9 174 0.5× 441 1.2× 52 0.3× 10 0.1× 212 2.5× 9 669
Lisa McPherson United States 17 568 1.5× 735 2.1× 31 0.2× 18 0.1× 306 3.6× 24 1.2k
Stéphanie Sentis France 12 361 1.0× 861 2.4× 19 0.1× 36 0.3× 269 3.2× 16 1.1k
Deborah A. Katz United States 15 386 1.0× 503 1.4× 33 0.2× 37 0.3× 249 2.9× 32 840
Naohiro Ariga Japan 9 259 0.7× 214 0.6× 10 0.1× 16 0.1× 278 3.3× 10 553
María C. Díaz Flaqué Argentina 14 96 0.3× 299 0.8× 12 0.1× 44 0.3× 314 3.7× 23 627
Heidi N. Hilton Australia 11 309 0.8× 370 1.0× 12 0.1× 26 0.2× 431 5.1× 15 771
Karl Hartmut Richter Germany 11 89 0.2× 371 1.0× 7 0.0× 40 0.3× 148 1.7× 15 593

Countries citing papers authored by P.J. Gomes

Since Specialization
Citations

This map shows the geographic impact of P.J. Gomes's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P.J. Gomes with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P.J. Gomes more than expected).

Fields of papers citing papers by P.J. Gomes

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by P.J. Gomes. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P.J. Gomes. The network helps show where P.J. Gomes may publish in the future.

Co-authorship network of co-authors of P.J. Gomes

This figure shows the co-authorship network connecting the top 25 collaborators of P.J. Gomes. A scholar is included among the top collaborators of P.J. Gomes based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with P.J. Gomes. P.J. Gomes is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Silva, Graça Miranda, Pier Paolo Patrucco, & P.J. Gomes. (2025). Advancing green supply chains through downstream digitalization: An information processing theory perspective. Journal of Purchasing and Supply Management. 31(5). 101015–101015. 1 indexed citations
2.
Gomes, P.J., et al.. (2023). Bilastine 0.6% Preservative-free Eye Drops: A Once-daily Treatment for Allergic Conjunctivitis. Journal of Investigational Allergology and Clinical Immunology. 34(3). 167–176. 6 indexed citations
3.
Silva, Graça Miranda & P.J. Gomes. (2023). Lean production, green supply chain management and environmental performance: a configurational perspective based on the Portuguese context. International Journal of Lean Six Sigma. 16(2). 518–541. 4 indexed citations
5.
Smith, Lisa M., et al.. (2016). Ocular itch associated with allergic conjunctivitis: latest evidence and clinical management. Therapeutic Advances in Chronic Disease. 7(1). 52–67. 57 indexed citations
6.
Gomes, P.J.. (2014). Trends in prevalence and treatment of ocular allergy. Current Opinion in Allergy and Clinical Immunology. 14(5). 451–456. 37 indexed citations
7.
Gomes, P.J. & Mark B. Abelson. (2012). Comparison of Environmental and Allergen-Challenge based Assessments of Allergic Conjunctivitis Treatment using an Antihistamine-Steroid Combination Therapy. Journal of Allergy and Clinical Immunology. 129(2). AB190–AB190. 1 indexed citations
8.
Torkildsen, Gail, et al.. (2009). Bepotastine Besilate Ophthalmic Solution 1.5% Reduces Ocular Itching in a Clinical Model of Allergic Conjunctivitis. Journal of Allergy and Clinical Immunology. 123(2). S57–S57. 3 indexed citations
10.
Protzko, Eugene, et al.. (2009). The Safety of the Anti-Histamine Bepotastine Besilate Ophthalmic Solution in a Healthy Pediatric Population From Ten to Seventeen Years of Age. 50(13). 6325–6325. 2 indexed citations
12.
Gomes, P.J., et al.. (2006). Evaluation of the Effect of Multiple Doses of Pred Forte (Prednisolone Acetate 1%) in the Prevention of Conjunctival Allergen Challenge–Induced Ocular Allergic Signs and Symptoms. 47(13). 4978–4978. 1 indexed citations
13.
Berger, William E., et al.. (2005). Effects of adjuvant therapy with 0.1% olopatadine hydrochloride ophthalmic solution on quality of life in patients with allergic rhinitis using systemic or nasal therapy. Annals of Allergy Asthma & Immunology. 95(4). 361–371. 39 indexed citations
14.
Gomes, P.J., et al.. (2005). Africa. World Bank eBooks. 1 indexed citations
15.
Ousler, George W, P.J. Gomes, Donna Welch, & Mark B. Abelson. (2005). Methodologies for the Study of Ocular Surface Disease. The Ocular Surface. 3(3). 143–154. 58 indexed citations
16.
Gomes, P.J., et al.. (2004). Allergic Rhinoconjunctivitis is Mediated Primarily through Ocular Exposure to Allergen.. 45(13). 4849–4849.
17.
Abelson, Mark B., P.J. Gomes, Donna Welch, et al.. (2004). Olopatadine 0.2% is Effective for the Once Daily Treatment of the Ocular Signs and Symptoms Associated with Allergic Conjunctivitis. 45(13). 4824–4824. 1 indexed citations
18.
Abelson, Mark B., et al.. (2003). Olopatadine Reduces Ocular Signs and Symptoms Associated With Allergic Conjunctivitis 16 Hours After Instillation. Investigative Ophthalmology & Visual Science. 44(13). 3736–3736. 3 indexed citations
19.
Li, Hui, et al.. (1997). RAC3, a steroid/nuclear receptor-associated coactivator that is related to SRC-1 and TIF2. Proceedings of the National Academy of Sciences. 94(16). 8479–8484. 496 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026